Skip to content
REMAP-ILD logo linking to homepage
  • Home
  • About
  • Our team
  • Our stories
  • Useful links
  • Resources
  • News
Back to top Go to content
REMAP ILD
  • Home
  • About
  • Our team
  • Our stories
  • Useful links
  • Resources
  • News

Embark on a journey with us as we attempt to establish a ground-breaking study to find treatments faster for patients with interstitial lung disease (ILD).

Family sitting outdoors near their recreational vehicle

REMAP-ILD has the potential to revolutionise the way clinical trials are run and help find treatments faster.

We need to move quickly and effectively to transform patients’ lives as rapidly as possible. Discover more information on this website about this ambitious project.

  • What does living with ILD mean?

    What does living with ILD mean?

    When fibrotic ILD progress, patients have increasing symptoms that limit everyday activities and often need oxygen therapy - having devastating impact on quality of life.

    Read more
  • What is a REMAP trial?

    What is a REMAP trial?

    In a REMAP trial, many different treatments and combinations of treatments can be tested at the same time, and the results can be understood sooner.

    Read more
  • Support the project

    Support the project

    We are growing a worldwide REMAP-ILD community of patients and caregivers, biotech firms, academics, researchers and clinicians. Securing funding is critical to the next stage of the project.

    Read more

Who is involved?

It is a collaborative project involving ILD experts from around the world, bringing together scientists, clinicians, patients, patient organisations and industry.

Read more

REMAP-ILD world map

Meet the team

  • Manuela Funke-Chambour

    Manuela Funke-Chambour

    Chief Physician and Deputy Director of the Pulmonary Department

    University Hospital in Bern, Switzerland

  • Iain Stewart

    Iain Stewart

    Advanced Research Fellow

    National Heart & Lung Institute, Imperial, UK

  • Leticia Kawano-Dourado

    Leticia Kawano-Dourado

    REMAP-ILD Global Head of Operations

    HCor Research Institute & University Sao Paulo, Brazil & MAGIC Evidence Ecosystem Foundation, Norway

  • Yasuhiro Kondoh

    Yasuhiro Kondoh

    RMC Lead

    REMAP-ILD

  • Teja Kulkarni

    Teja Kulkarni

    Director of ILD

    University of Alabama at Birmingham, US

  • Michael Kreuter

    Michael Kreuter

    Professor of Pulmonology

    University of Mainz, Germany

  • Gisli Jenkins

    Gisli Jenkins

    REMAP-ILD Global Lead & Margaret Turner Warwick Chair of Thoracic Medicine

    National Heart & Lung Institute, Imperial, UK

  • Anne E Holland

    Anne E Holland

    Professor of Physiotherapy and Head of Respiratory Research

    Monash University and Alfred Health in Melbourne, Australia

  • Gary M Hunninghake

    Gary M Hunninghake

    Pulmonologist, Genetic Epidemiologist, Associate Director

    Brigham and Women's Hospital, Boston, US

  • Tyler Pitre

    Tyler Pitre

    Respirology Fellow

    University of Toronto, Canada

    Tilted large lung graphic

    Faculty of Medicine
    Imperial College London
    Level 2, Faculty Building
    South Kensington Campus
    London SW7 2AZ, UK

    Imperial College London logo

    Funded by National Institute for Health Research (NIHR) logo

    Website by Volute

    Accessibility | Privacy

    Icon: This website is powered by 100% renewable energy
    Icon: Click here to find out more